J&J to stop selling opioids in US, reaches $230 mn settlement with New York
June 27, 2021 | 08:10
Johnson & Johnson, one of the pharmaceutical giants accused of fueling the deadly US opioid crisis, has reached a settlement with the state of New York for $230 million and confirmed it will stop making or selling opioids in the United States.
Mobile Version